The continuing CRISPR patent battle: the Broad Institute loses a key European patent – MedCity News
MedCity News |
The continuing CRISPR patent battle: the Broad Institute loses a key European patent
MedCity News In the ongoing worldwide patent battle over the CRISPR Cas9 gene-editing technology between the Broad Institute/MIT (Zhang, et al.), and the University of California/University of Vienna (Doudna/Charpentier, et al.), Broad suffered a stunning blow at … |
